Dec 16 (Reuters) - Mylan NV said on Friday it would
start selling a generic version of its life-saving EpiPen
allergy treatment at a more than 50 percent discount, a day
after 20 U.S. states filed a lawsuit against generic drugmakers
including Mylan over prices.
Read more
No comments:
Post a Comment